Urade
Vikrant N. Urade, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20110278533 | DOUBLE GYROID STRUCTURE NANOPOROUS FILMS AND NANOWIRE NETWORKS - A method of forming a nanoporous film is disclosed. The method comprises forming a coating solution including clusters, surfactant molecules, a solvent, and one of an acid catalyst and a base catalyst. The clusters comprise inorganic groups. The method further comprises aging the coating solution for a time period to select a predetermined phase that will self-assemble and applying the coating solution on a substrate. The method further comprises evaporating the solvent from the coating solution and removing the surfactant molecules to yield the nanoporous film. | 11-17-2011 |
Vikrant Nanasaheb Urade, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150336088 | CATALYST AND METHOD FOR PREPARATION THEREOF - A process for converting one or more C3-C12 oxygenates comprising: contacting a feed, which feed comprises one or more C3-C12 oxygenates, with hydrogen at a hydrogen partial pressure of more than 1.0 MegaPascal in the presence of a sulphided carbon-carbon coupling catalyst; wherein the carbon-carbon coupling catalyst comprises equal to or more than 60 wt % of a zeolite and in the range from equal to or more than 0.1% wt to equal to or less than 10 wt % of a hydrogenation metal, based on the total weight of the carbon-carbon coupling catalyst; and wherein the zeolite comprises 10-membered and/or 12-membered ring channels and a Silica to Alumina molar Ratio (SAR) in the range from equal to or more than 10 to equal to or less than 300. | 11-26-2015 |
20150337215 | PROCESSS FOR CONVERTING A BIOMASS MATERIAL - A process for converting a biomass material comprising a) converting a biomass material in one or more steps into one or more C3-C12 oxygenates; b) contacting the one or more C3-C12 oxygenates with hydrogen at a hydrogen partial pressure of more than 1.0 MegaPascal in the presence of a sulphided carbon-carbon coupling catalyst; wherein the carbon-carbon coupling catalyst comprises equal to or more than 60 wt % of a zeolite and in the range from equal to or more than 0.1% wt to equal to or less than 10 wt % of a hydrogenation metal, based on the total weight of the carbon-carbon coupling catalyst. | 11-26-2015 |
20150337216 | PROCESS FOR CONVERTING ONE OR MORE C3-C12 OXYGENATES - A process for converting one or more C3-C12 oxygenates comprising: | 11-26-2015 |
20150337217 | A PROCESS FOR CONVERTING ONE OR MORE C3-C12 OXYGENATES - A process for converting one or more C3-C12 oxygenates comprising oxygenates comprising: contacting a feed, which feed comprises one or more C3-C12 oxygenates, with hydrogen at a hydrogen partial pressure of more than 1.0 Mega Pascal in the presence of a sulphided carbon-carbon coupling catalyst; wherein the carbon-carbon coupling catalyst comprises equal to or more than 60 wt % of a zeolite and in the range from equal to or more than 0.1 wt % to equal to or less than 10 wt % of a hydrogenation metal, based on the total weight of the carbon-carbon coupling catalyst; and wherein the zeolite comprises 10-membered and/or 12-membered ring channels and a Silica to Alumina molar Ratio (SAR) in the range from equal to or more than 10 to equal to or less than 300. | 11-26-2015 |
Yoshihiro Urade, Kyoto-Shi JP
Patent application number | Description | Published |
---|---|---|
20090263784 | THREE-DIMENSIONAL STRUCTURE OF PROSTAGLANDIN D SYNTHASE AND UTILIZATION THEREOF - A method of designing an anti-allergic agent, sleep controlling agent, anti-obesity agent and remedy for brain injury acting via the inhibition of biosynthesis of prostaglandin D | 10-22-2009 |
20100286415 | SLEEP-IMPROVING AGENT - The invention provides a sleep-improving agent and a sedative agent containing, as an active ingredient, oxypinnatanine or its derivative represented by the following chemical formula (I): | 11-11-2010 |
20120309760 | PIPERAZINE COMPOUND HAVING A PGDS INHIBITORY EFFECT - The present invention provides a piperazine compound represented by Formula (I) or a salt thereof, | 12-06-2012 |
20130165438 | PROSTAGLANDIN D SYNTHASE INHIBITORY PIPERIDINE COMPOUNDS - The present invention provides a piperidine compound represented by Formula (I) | 06-27-2013 |
Yoshihiro Urade, Kyoto JP
Patent application number | Description | Published |
---|---|---|
20080233597 | Method of Detecting or Differentiating Rheumatoid Arthritis and Method of Determining Stage of Disease or Degree of Dysfunction with Regard to Rheumatoid Arthritis - A method of readily detecting or differentiating rheumatoid arthritis, which has so far been diagnosed in a comprehensive manner based on various tests and clinical symptoms, and a method of readily and objectively estimating the stage of disease and the degree of dysfunction with regard to rheumatoid arthritis are provided. | 09-25-2008 |
20090281098 | BENZOIMIDAZOLE COMPOUND CAPABLE OF INHIBITING PROSTAGLANDIN D SYNTHETASE - The present invention provides a benzimidazole compound represented by Formula (I) | 11-12-2009 |
20100138937 | Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease - A method for diagnosis of the severity of a condition in an eosinophilic inflammatory disease such as nasal polyp or for prediction of the recurrence of the disease, the method comprising detecting H-PGDS induced by eosinophilic leukocytes accumulated in a lesion or determining pGD | 06-03-2010 |
Yoshihiro Urade, Osaka JP
Patent application number | Description | Published |
---|---|---|
20110318764 | METHOD FOR DETECTING MUSCLE DEGENERATIVE DISEASES, AND METHOD FOR DETERMINING THERAPEUTIC EFFICACY ON THE DISEASES - Muscle degenerative diseases can be detected in the early stage and the therapeutic efficacy of a therapeutic agent and/or a therapy method for the diseases can be determined by measuring 11,15-dioxo-9α-hydroxy-2,3,4,5-tetranorprostan-1,20-dioic acid (referred to as “Tetranor-PGDM”, hereinbelow) in a sample isolated from a subject. | 12-29-2011 |
20110319413 | PIPERAZINE COMPOUND CAPABLE OF INHIBITING PROSTAGLANDIN D SYNTHASE - This invention relates to a piperazine compound represented by Formula (I), | 12-29-2011 |
20140128394 | PIPERAZINE COMPOUND CAPABLE OF INHIBITING PROSTAGLANDIN D SYNTHASE - This invention relates to a piperazine compound represented by Formula (I), | 05-08-2014 |
Yoshihiro Urade, Ibaraki JP
Patent application number | Description | Published |
---|---|---|
20140248383 | SLEEP QUALITY IMPROVING AGENT - An object is to provide a sleep quality improving agent that can sufficiently exert the effect of improving the quality of sleep and ensures safety for the body. A sleep quality improving agent containing, as an effective ingredient, a plant of the | 09-04-2014 |
20150147418 | SLEEP QUALITY IMPROVING AGENT - An object of the present invention is to provide a sleep quality improving agent which has a sufficient sleep quality improving effect, can exert makes the effect even through oral administration in any dosage form, and has ensured safety to the body. That is, the present invention provides: a sleep quality improving agent which contains a stilbene-based compound and/or an olive extract as an active ingredient, and a sleep quality improving composition which contains the sleep quality improving agent. | 05-28-2015 |